Published in Am J Surg on October 01, 1983
Osteoclasts and the resorption of bone by transplanted mammary carcinoma in rats. Br J Cancer (1985) 0.79
Patterns and mechanisms of bone metastases. J R Soc Med (1985) 0.78
Marginal mandibulectomy in oral cancer surgery: a 13-year experience. Eur Arch Otorhinolaryngol (2009) 0.76
Mandibular invasion of squamous cell carcinoma: factors determining surgical resection of mandible using computerized tomography and histopathologic study. J Maxillofac Oral Surg (2010) 0.75
Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med (1982) 12.33
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res (1968) 7.53
Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res (2005) 4.41
Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst (1970) 3.94
Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med (2007) 3.75
Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A (1966) 3.56
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56
An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst (1971) 3.30
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst (1969) 3.07
Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med (1968) 3.01
The morphology of immune reactions in normal, thymectomized and reconstituted mice. II. The response to oxazolone. Immunology (1969) 2.69
The pathological effects of subcutaneous injections of asbestos fibres in mice: migration of fibres to submesothelial tissues and induction of mesotheliomata. Int J Cancer (1967) 2.65
Further studies on the treatment of Burkitt's lymphoma. East Afr Med J (1966) 2.61
The morphology of immune reactions in normal, thymectomized and reconstituted mice. 3. Response to bacterial antigens: salmonellar flagellar antigen and pneumococcal plysaccharide. Immunology (1970) 2.53
The morphology of immune reactions in normal, thymectomized and reconstituted mice. I. The response to sheep erythrocytes. Immunology (1969) 2.49
T-cell activation in murine malaria. Nature (1975) 2.23
Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. Cancer Res (1967) 2.01
Chromium carcinogenesis: calcium chromate as a potent carcinogen for the subcutaneous tissues of the rat. Br J Cancer (1969) 1.98
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res (1993) 1.89
The styloid process syndrome: aetiological factors and surgical management. J Laryngol Otol (1977) 1.88
Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet (1978) 1.85
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene (2006) 1.82
Cancer hazard from mineral oil used in the processing of jute. Br J Cancer (1967) 1.76
Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Br J Cancer (1981) 1.70
Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. Clin Exp Immunol (1969) 1.68
On concomitant immunity in tumour-bearing hamsters. Nature (1967) 1.59
The immunological response of CBA mice to P. yoelii. I. General characteristics, the effects of T-cell deprivation and reconstitution with thymus grafts. Immunology (1977) 1.54
High molecular weight kininogen deficiency: a patient who underwent cardiac surgery. Thromb Haemost (2001) 1.52
Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J Natl Cancer Inst (1967) 1.52
Structural changes in memebranes of synchronized cells demonstrated by freeze-cleavage. Nature (1971) 1.51
Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet (1985) 1.48
Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol (1994) 1.48
Surgace IgM specificity on cells derived from a Burkitt's lymphoma. Lancet (1967) 1.46
Characteristics of new cell lines derived from Burkitt lymphomas. Cancer (1969) 1.46
Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. J Natl Cancer Inst (1971) 1.43
Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med (1973) 1.42
Identification of a red pigment from Streptomyces coelicolor A3(2) as a mixture of prodigiosin derivatives. J Antibiot (Tokyo) (1985) 1.41
Effect of birth weight, race, and sex on survival of low-birth-weight infants in neonatal intensive care. Am J Obstet Gynecol (1989) 1.40
Drugs in donated blood. Lancet (1989) 1.39
Carcinoma of the nasopharynx in Kenya. East Afr Med J (1965) 1.39
Antibody formation in infectious mononucleosis. II. Other 19S antibodies and false-positive serology. Br J Haematol (1966) 1.37
Treatment of Burkitt's lymphoma. Lancet (1968) 1.37
Mixed-effects nonlinear regression for unbalanced repeated measures. Biometrics (1992) 1.36
Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells. Carcinogenesis (2000) 1.35
The immunopathology of trichiniasis in T-cell deficient mice. Clin Exp Immunol (1973) 1.32
Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival. Cancer Res (1967) 1.31
Over expression of ID-1 in prostate cancer. J Urol (2002) 1.31
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. J Med Chem (1999) 1.31
Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene (2011) 1.31
A review on the epidemiology of nasopharyngeal carcinoma. Int J Cancer (1970) 1.30
Tunable mechanically induced long-period fiber gratings. Opt Lett (2000) 1.29
Clonal origin for individual Burkitt tumours. Lancet (1970) 1.27
Direct membrane immunofluorescence reaction of Burkitt's lymphoma cells in culture. Cancer Res (1969) 1.27
Carcinogens in the nose and throat: nasopharyngeal carcinoma in Kenya. Proc R Soc Med (1972) 1.27
Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence. J Exp Med (1969) 1.26
Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers. J Biol Chem (1992) 1.26
Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer (2006) 1.23
Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus. J Natl Cancer Inst (1970) 1.23
Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature (1970) 1.22
A national audit of new long-stay psychiatric patients. I: Method and description of the cohort. Br J Psychiatry (1994) 1.21
Diet therapy for rheumatoid arthritis. Arthritis Rheum (1983) 1.21
Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol (1999) 1.20
Perineural spread in squamous cell carcinomas of the head and neck: a clinicopathological study. Clin Otolaryngol Allied Sci (1979) 1.19
Cancer of the paranasal sinuses and nasal cavities. Part II. Results of treatment. J Laryngol Otol (1984) 1.18
Efficient inference for random-coefficient growth curve models with unbalanced data. Biometrics (1987) 1.18
Induction of hepatomas by 4-aminobiphenyl and three of its hydroxylated derivatives administered to newborn mice. J Natl Cancer Inst (1968) 1.18
The serum vitamin B12 level: its assay and significance. Clin Haematol (1976) 1.17
Foreign-cell contamination in Burkitt tumours. Lancet (1971) 1.16
Kinetically-based multiple drug treatment for advanced head and neck cancer. Br Med J (1975) 1.15
EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions. Int J Cancer (1972) 1.14
Inherited lack of transcobalamin II in serum and megaloblastic anaemia: a further patient. Br J Haematol (1979) 1.14
EB viral antigens in Burkitt tumor biopsies and early cultures. Int J Cancer (1970) 1.13
Replication of age and physical activity effects on reaction and movement time. J Gerontol (1978) 1.12
Infectious mononucleosis: model for self-limiting lymphoproliferation. Lancet (1975) 1.12
Balkan (endemic) nephropathy and a toxin-producing strain of Penicillium verrucosum var cyclopium: An experimental model in rats. Lancet (1977) 1.11
Carcinogenic properties of certain rubber additives. Eur J Cancer (1968) 1.11
Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation. Br J Cancer (1983) 1.11
Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol (1997) 1.11
Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromes. Postgrad Med J (1987) 1.10
Iron-dextran carcinogenesis in rats: influence of dose on the number and types of neoplasm induced. Int J Cancer (1967) 1.10
Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens. Carcinogenesis (1999) 1.10
Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol (1984) 1.10
The outcome in the United States after thoracoabdominal aortic aneurysm repair, renal artery bypass, and mesenteric revascularization. J Vasc Surg (2001) 1.08
Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells. Mol Carcinog (2005) 1.08
Release of Escherichia coli DNA from membrane complexes by single-strand endonucleases. Proc Natl Acad Sci U S A (1977) 1.08
Histological changes evoked in mice by Freund's complete adjuvant. J Pathol (1969) 1.08
Studies on homotransplantable lymphomas in hamsters. I. Histologic responses in lymphoid tissues and their relationship to metastasis. Am J Pathol (1966) 1.07
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations. J Med Chem (1996) 1.07
On the persistence of tumour initiation and the acceleration of tumour progression in mouse skin tumorigenesis. Int J Cancer (1972) 1.07
Synchronous VBM and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. Clin Otolaryngol Allied Sci (1977) 1.07
Developmental intervention program for high-risk premature infants: effects on development and parent-infant interactions. J Dev Behav Pediatr (1988) 1.07
Prostaglandin-like material extracted from squamous carcinomas of the head and neck. Br J Cancer (1980) 1.06
Cyclophosphamide pretreatment reduces the toxic effect of high dose melphalan on intestinal epithelium in sheep. Eur J Cancer (1978) 1.06
Induction of lymphoma in BALB-c mice by Rowson-Parr virus (RPV). Int J Cancer (1970) 1.06
Advanced trauma life support in the UK: 8 years on. Br J Hosp Med (1997) 1.06